CD8A and neoplasm: One of the common tumour intrinsic ways to suppress CD8+ cytotoxic T lymphocytes (CTLs) is to upregulate negative immune checkpoint molecules on the cell surface including the most studied molecule PD-L1, and also several others, HVEM, PVR, PVRL2 and CD276 [19–22].